Bank of Montreal’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bank of Montreal’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-121,800	Closed	-$11M	–	3767
2024 Q4	$11M	Buy	121,800 +100,000	+459%	+$9.69M	0.01%	958
2024 Q3	$2.15M	Buy	+21,800	New	+$2.14M	﹤0.01%	1677
2023 Q3	–	Sell	-15,000	Closed	-$1.32M	–	4279
2023 Q2	$1.32M	Buy	+15,000	New	+$1.25M	﹤0.01%	2025
2023 Q1	–	Sell	-85,000	Closed	-$7.07M	–	4238
2022 Q4	$7.07M	Sell	85,000 -240,600	-74%	-$19.5M	﹤0.01%	1130
2022 Q3	$28K	Buy	325,600 +300,000	+1,172%	+$25.3M	0.01%	570
2022 Q2	$1.93K	Sell	25,600 -53,000	-67%	-$3.98M	﹤0.01%	1910
2022 Q1	$7.36M	Buy	+78,600	New	+$7.26M	﹤0.01%	1298
2021 Q1	–	Sell	-35,000	Closed	-$5.18M	–	5378
2020 Q4	$5.18M	Hold	35,000	–	–	﹤0.01%	1358
2020 Q3	$4.02M	Buy	+35,000	New	+$3.92M	﹤0.01%	1331

Other funds holding XBI

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return

MSR

Main Street Research Lakeville, Connecticut $2.12B AUM 67.44% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Bank of Montreal's XBI Position: Q2 2026 in Review

Bank of Montreal reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 5.4% in Q2 2026, selling an estimated $6.13M and leaving 789,273 shares worth $125M. The position accounts for 0.04% of the portfolio, ranked #338.

Bank of Montreal first reported a position in XBI in Q2 2014 and has held it in 49 quarters since. 692 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Bank of Montreal held 789,273 shares of State Street SPDR S&P Biotech ETF worth $125M as of Q2 2026.
Bank of Montreal sold 45,357 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $6.13M.
State Street SPDR S&P Biotech ETF made up 0.04% of Bank of Montreal's portfolio in Q2 2026, its #338 holding.
Bank of Montreal first reported a position in State Street SPDR S&P Biotech ETF in Q2 2014 and has held it in 49 quarters since.
692 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.